Randomized trial of GM-CSF and G-CSF following high-dose cytarabine and mitoxantrone chemotherapy for relapsed and refractory acute leukemia.

被引：0
|
作者：
Baer, Maria R. [1 ]
Ford, Laurie A. [1 ]
Bundy, Brian N. [1 ]
Tighe, Sheila M. [1 ]
O'Loughlin, Kieran L. [1 ]
Slack, James L. [1 ]
Wetzler, Meir [1 ]
Wallace, Paul K. [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4574
引用
收藏
页码：223B / 223B
页数：1
相关论文
共 50 条
  • [1] FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children
    McCarthy, AJ
    Pitcher, LA
    Hann, IM
    Oakhill, A
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 32 (06): : 411 - 415
  • [2] FLAG (fludarabine, high-dose cytarabine and G-CSF) for refractory and high-risk relapsed acute leukemia in children
    Sarper, N
    Yalman, N
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 34 (02): : 163 - 163
  • [3] Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
    Halpern, Anna B.
    Othus, Megan
    Huebner, Emily M.
    Scott, Bart L.
    Hendrie, Paul C.
    Percival, Mary-Elizabeth M.
    Becker, Pamela S.
    Smith, Heather A.
    Oehler, Vivian G.
    Orozco, Johnnie J.
    Cassaday, Ryan D.
    Gardner, Kelda M.
    Chen, Tara L.
    Buckley, Sarah A.
    Orlowski, Kaysey F.
    Anwar, Asma
    Estey, Elihu H.
    Walter, Roland B.
    HAEMATOLOGICA, 2019, 104 (04) : E143 - E146
  • [4] G-CSF Priming, Clofarabine and High Dose Cytarabine (GCLAC) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Storer, Barry E.
    Appelbaum, Frederick R.
    BLOOD, 2009, 114 (22) : 816 - 816
  • [5] Phase III trial with or without GM-CSF administered before and during high dose cytarabine in patients with relapsed or refractory acute myelogenous leukemia. CALGB 9021.
    Peterson, BA
    George, SL
    Bhalla, K
    Lee, E
    Carpenter, JT
    Berk, GI
    Schiffer, CA
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 2016 - 2016
  • [6] Phase I Trial of Clofarabine and High Dose Cytarabine with G-CSF Priming (G-CLAC) for Relapsed or Refractory Acute Myeloid Leukemia
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Hendrie, Paul C.
    Pagel, John M.
    Stirewalt, Derek
    Shustov, Andrei
    Storer, Barry E.
    Appelbaum, Frederick R.
    BLOOD, 2008, 112 (11) : 1018 - 1018
  • [7] Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy
    G Spitzer
    D Adkins
    M Mathews
    W Velasquez
    C Bowers
    F Dunphy
    N Kronmueller
    R Niemeyer
    W McIntyre
    P Petruska
    Bone Marrow Transplantation, 1997, 20 : 921 - 930
  • [8] CYTOKINE THERAPY OF GRAFT FAILURE FOLLOWING MARROW TRANSPLANTATION - A RANDOMIZED TRIAL OF GM-CSF VS GM-CSF PLUS G-CSF
    WEISDORF, DJ
    BURROUGHS, J
    VERFAILLIE, C
    DAVIES, S
    FILIPOVICH, A
    WAGNER, J
    RAMSAY, NKC
    KERSEY, JH
    MCGLAVE, PB
    BLAZAR, BR
    BLOOD, 1994, 84 (10) : A88 - A88
  • [9] A randomized trial on the hematological and extra hematological effects of adding GM-CSF to postransplant G-CSF after high-dose chemotherapy with stem cell rescue.
    Murillo, L
    Yubero, A
    Isla, D
    Mayordomo, JI
    Cajal, R
    Palomera, L
    Moreno, JA
    Herráez, J
    Bueso, P
    Martí, JL
    Escudero, P
    Sáenz, A
    García, MD
    Tres, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S97 - S97
  • [10] Do G-CSF and GM-CSF contribute to the management of acute lymphoblastic leukemia?
    Ottmann, OG
    Hoelzer, D
    LEUKEMIA, 1996, 10 : S52 - S57
12345